2020 ICD-10-CM POA Exempt - Agents primarily affecting the cardiovascular system (T46)

List of Present On Admission Exempt (POA) ICD-10-CM Codes for: "Agents primarily affecting the cardiovascular system (T46)" for the fiscal year 2020. There are 132 diagnosis codes exempt from POA reporting in this chapter.

ICD-10 Description Status
T46.0X1DPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounterBillable Code
T46.0X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequelaBillable Code
T46.0X2DPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounterBillable Code
T46.0X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequelaBillable Code
T46.0X3DPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounterBillable Code
T46.0X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequelaBillable Code
T46.0X4DPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounterBillable Code
T46.0X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequelaBillable Code
T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounterBillable Code
T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequelaBillable Code
T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounterBillable Code
T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequelaBillable Code
T46.1X1DPoisoning by calcium-channel blockers, accidental (unintentional), subsequent encounterBillable Code
T46.1X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequelaBillable Code
T46.1X2DPoisoning by calcium-channel blockers, intentional self-harm, subsequent encounterBillable Code
T46.1X2SPoisoning by calcium-channel blockers, intentional self-harm, sequelaBillable Code
T46.1X3DPoisoning by calcium-channel blockers, assault, subsequent encounterBillable Code
T46.1X3SPoisoning by calcium-channel blockers, assault, sequelaBillable Code
T46.1X4DPoisoning by calcium-channel blockers, undetermined, subsequent encounterBillable Code
T46.1X4SPoisoning by calcium-channel blockers, undetermined, sequelaBillable Code
T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounterBillable Code
T46.1X5SAdverse effect of calcium-channel blockers, sequelaBillable Code
T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounterBillable Code
T46.1X6SUnderdosing of calcium-channel blockers, sequelaBillable Code
T46.2X1DPoisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounterBillable Code
T46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequelaBillable Code
T46.2X2DPoisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounterBillable Code
T46.2X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequelaBillable Code
T46.2X3DPoisoning by other antidysrhythmic drugs, assault, subsequent encounterBillable Code
T46.2X3SPoisoning by other antidysrhythmic drugs, assault, sequelaBillable Code
T46.2X4DPoisoning by other antidysrhythmic drugs, undetermined, subsequent encounterBillable Code
T46.2X4SPoisoning by other antidysrhythmic drugs, undetermined, sequelaBillable Code
T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounterBillable Code
T46.2X5SAdverse effect of other antidysrhythmic drugs, sequelaBillable Code
T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounterBillable Code
T46.2X6SUnderdosing of other antidysrhythmic drugs, sequelaBillable Code
T46.3X1DPoisoning by coronary vasodilators, accidental (unintentional), subsequent encounterBillable Code
T46.3X1SPoisoning by coronary vasodilators, accidental (unintentional), sequelaBillable Code
T46.3X2DPoisoning by coronary vasodilators, intentional self-harm, subsequent encounterBillable Code
T46.3X2SPoisoning by coronary vasodilators, intentional self-harm, sequelaBillable Code
T46.3X3DPoisoning by coronary vasodilators, assault, subsequent encounterBillable Code
T46.3X3SPoisoning by coronary vasodilators, assault, sequelaBillable Code
T46.3X4DPoisoning by coronary vasodilators, undetermined, subsequent encounterBillable Code
T46.3X4SPoisoning by coronary vasodilators, undetermined, sequelaBillable Code
T46.3X5DAdverse effect of coronary vasodilators, subsequent encounterBillable Code
T46.3X5SAdverse effect of coronary vasodilators, sequelaBillable Code
T46.3X6DUnderdosing of coronary vasodilators, subsequent encounterBillable Code
T46.3X6SUnderdosing of coronary vasodilators, sequelaBillable Code
T46.4X1DPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounterBillable Code
T46.4X1SPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequelaBillable Code
T46.4X2DPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounterBillable Code
T46.4X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequelaBillable Code
T46.4X3DPoisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounterBillable Code
T46.4X3SPoisoning by angiotensin-converting-enzyme inhibitors, assault, sequelaBillable Code
T46.4X4DPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounterBillable Code
T46.4X4SPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequelaBillable Code
T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounterBillable Code
T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequelaBillable Code
T46.4X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounterBillable Code
T46.4X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequelaBillable Code
T46.5X1DPoisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounterBillable Code
T46.5X1SPoisoning by other antihypertensive drugs, accidental (unintentional), sequelaBillable Code
T46.5X2DPoisoning by other antihypertensive drugs, intentional self-harm, subsequent encounterBillable Code
T46.5X2SPoisoning by other antihypertensive drugs, intentional self-harm, sequelaBillable Code
T46.5X3DPoisoning by other antihypertensive drugs, assault, subsequent encounterBillable Code
T46.5X3SPoisoning by other antihypertensive drugs, assault, sequelaBillable Code
T46.5X4DPoisoning by other antihypertensive drugs, undetermined, subsequent encounterBillable Code
T46.5X4SPoisoning by other antihypertensive drugs, undetermined, sequelaBillable Code
T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounterBillable Code
T46.5X5SAdverse effect of other antihypertensive drugs, sequelaBillable Code
T46.5X6DUnderdosing of other antihypertensive drugs, subsequent encounterBillable Code
T46.5X6SUnderdosing of other antihypertensive drugs, sequelaBillable Code
T46.6X1DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounterBillable Code
T46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequelaBillable Code
T46.6X2DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounterBillable Code
T46.6X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequelaBillable Code
T46.6X3DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounterBillable Code
T46.6X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequelaBillable Code
T46.6X4DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounterBillable Code
T46.6X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequelaBillable Code
T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterBillable Code
T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequelaBillable Code
T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounterBillable Code
T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequelaBillable Code
T46.7X1DPoisoning by peripheral vasodilators, accidental (unintentional), subsequent encounterBillable Code
T46.7X1SPoisoning by peripheral vasodilators, accidental (unintentional), sequelaBillable Code
T46.7X2DPoisoning by peripheral vasodilators, intentional self-harm, subsequent encounterBillable Code
T46.7X2SPoisoning by peripheral vasodilators, intentional self-harm, sequelaBillable Code
T46.7X3DPoisoning by peripheral vasodilators, assault, subsequent encounterBillable Code
T46.7X3SPoisoning by peripheral vasodilators, assault, sequelaBillable Code
T46.7X4DPoisoning by peripheral vasodilators, undetermined, subsequent encounterBillable Code
T46.7X4SPoisoning by peripheral vasodilators, undetermined, sequelaBillable Code
T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounterBillable Code
T46.7X5SAdverse effect of peripheral vasodilators, sequelaBillable Code
T46.7X6DUnderdosing of peripheral vasodilators, subsequent encounterBillable Code
T46.7X6SUnderdosing of peripheral vasodilators, sequelaBillable Code
T46.8X1DPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounterBillable Code
T46.8X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequelaBillable Code
T46.8X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounterBillable Code
T46.8X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequelaBillable Code
T46.8X3DPoisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounterBillable Code
T46.8X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequelaBillable Code
T46.8X4DPoisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounterBillable Code
T46.8X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequelaBillable Code
T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounterBillable Code
T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequelaBillable Code
T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounterBillable Code
T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequelaBillable Code
T46.901DPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounterBillable Code
T46.901SPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequelaBillable Code
T46.902DPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounterBillable Code
T46.902SPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequelaBillable Code
T46.903DPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounterBillable Code
T46.903SPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequelaBillable Code
T46.904DPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounterBillable Code
T46.904SPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequelaBillable Code
T46.905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounterBillable Code
T46.905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequelaBillable Code
T46.906DUnderdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounterBillable Code
T46.906SUnderdosing of unspecified agents primarily affecting the cardiovascular system, sequelaBillable Code
T46.991DPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounterBillable Code
T46.991SPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequelaBillable Code
T46.992DPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounterBillable Code
T46.992SPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequelaBillable Code
T46.993DPoisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounterBillable Code
T46.993SPoisoning by other agents primarily affecting the cardiovascular system, assault, sequelaBillable Code
T46.994DPoisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounterBillable Code
T46.994SPoisoning by other agents primarily affecting the cardiovascular system, undetermined, sequelaBillable Code
T46.995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounterBillable Code
T46.995SAdverse effect of other agents primarily affecting the cardiovascular system, sequelaBillable Code
T46.996DUnderdosing of other agents primarily affecting the cardiovascular system, subsequent encounterBillable Code
T46.996SUnderdosing of other agents primarily affecting the cardiovascular system, sequelaBillable Code